VJHemOnc is committed to improving our service to you

ICML 2019 | Zanubrutinib in mantle cell lymphoma: updated safety and efficacy data

VJHemOnc is committed to improving our service to you

Constantine Tam

“Constantine Tam, MD, FRACP, FRCPA, Peter MacCallum Cancer Centre, Melbourne, Australia, presents the updates safety and efficacy data from the Phase I trial of zanubrutinib in mantle cell lymphoma (MCL). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter